Previous 10 |
CORAL GABLES, FL / ACCESSWIRE / March 6, 2019 / The tech stock market has been a hotbed of exciting conversation during the last few months as a result of word spreading about tech companies taking innovative approaches to create new technologies for the betterment of humankind. Stemming f...
Gainers: Bio-Path Holdings (NASDAQ: BPTH ) +180% . Renren (NYSE: RENN ) +47% . Seelos Therapeutics (NASDAQ: SEEL ) +28% . Abercrombie & Fitch (NYSE: ANF ) +24% . Aytu BioScience (NASDAQ: AYTU ) +24% . OHR Pharmaceutical (NASDAQ: OHRP ) +23% . Proteon Therapeutics (NASDAQ: P...
Thinly traded nano cap Ohr Pharmaceutical ( OHRP +23% ) bucks the sector's down day on more than 5x higher volume. More news on: Ohr Pharmaceutical, Inc., Healthcare stocks news, Stocks on the move, Read more ...
NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) today announced that it received notice from The Nasdaq Stock Market LLC indicating that the Company has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) (the "...
Thinly traded nano cap Ohr Pharmaceuticals ( OHRP +38% ) is up on almost a 17x surge in volume on no particular news. More news on: Ohr Pharmaceutical, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Gainers: 3Pea International (NASDAQ: TPNL ) +22% . Gemphire Therapeutics (NASDAQ: GEMP ) +19% . Hanesbrands (NYSE: HBI ) +18% . OHR Pharmaceutical (NASDAQ: OHRP ) +16% . Chipotle Mexican Grill (NYSE: CMG ) +14% . ION Geophysical (NYSE: IO ) +15% . CSG Systems International (NAS...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The market is moving in the right direction after some cooling off of Washington-Be...
NEW YORK, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (“Ohr” or the “Company”) (Nasdaq: OHRP) announced today that its board of directors has determined to effect a one-for-twenty reverse stock split of the Company's common stock, par value $0.0001...
News, Short Squeeze, Breakout and More Instantly...
Ohr Pharmaceutical Inc. Company Name:
OHRP Stock Symbol:
NASDAQ Market:
Ohr Pharmaceutical Inc. Website:
Company expects to initiate trading on NASDAQ Under Ticker Symbol “NBSE” effective July 15, 2019 Company completes previously announced financing of approximately $9 million immediately prior to closing of the merger Greenlight Capital agrees to purchase ~9% of Ne...
NEW YORK, July 10, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (“Ohr”) (Nasdaq: OHRP) today announced that all proposals related to its proposed merger with NeuBase Therapeutics, Inc. (“NeuBase”) were approved by Ohr’s stockholders at a special meeti...
-- Of the Votes Received to Date, More than 99% Are Voting in Favor of the Merger Proposal -- More Votes Are Needed to Reach 50% of the Outstanding Shares to Go Forward with the Special Meeting -- Every Vote Is Important to Avoid Delay in Completion of the Merger NEW YORK, July 03, ...